CI · Cigna Group
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted SG&A expense ratio non-GAAP | 4.6% | second quarter 2026 | — |
|
|
|||
| Behavioral Care | 27,621K | As of June 30, 2026 | -2.3% |
|
|
|||
| Cigna Healthcare MCR | 84.5% | second quarter 2026 | — |
| Dental | 18,488K | As of June 30, 2026 | +0.3% |
|
|
|||
| International Health | 1,735K | As of June 30, 2026 | +2.4% |
|
|
|||
| SG&A expense ratio | 4.8% | second quarter 2026 | — |
|
|
|||
| Total Customer Relationships | 182,765K | As of June 30, 2026 | -3.0% |
|
|
|||
| Total Medical Customers | 18,413K | As of June 30, 2026 | +1.6% |
|
|
|||
| Total Pharmacy Customers | 118,243K | As of June 30, 2026 | -4.3% |
|
|
|||
| U.S. Healthcare | 16,678K | As of June 30, 2026 | +1.6% |
|
|
|||
| debt-to-capitalization ratio | 42.3% | March 31, 2026 | — |
| Adjusted Income from Operations non-GAAP | $8,014M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Shareholders' Net Income $1,234M
+$104M Net Investment (Gains) Losses
+$327M Amortization of Acquired Intangible Assets
+$483M Special Items
= Adjusted Income from Operations $2,148M
|
|||
| Adjusted Income from Operations, per share non-GAAP | $29.84 | Year Ended December 31, 2025 | — |
| Adjusted Revenues non-GAAP | $274,651M | Year Ended December 31, 2025 | — |
| Shares repurchased | 11.9M | Year Ended December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CI
this stock
Cigna Group
|
$71.53B | +0.7% | +11.2% | 11.2 | 2.3% |
|
UNH
Unitedhealth Group Inc
|
$377.21B | +25.1% | +11.8% | 31.3 | 1.9% |
|
CVS
CVS HEALTH Corp
|
$127.47B | +34.7% | +10.9% | 26.3 | 1.5% |
|
ELV
Elevance Health, Inc.
|
$84.83B | +8.9% | +9.4% | 17.3 | 2.8% |
|
HUM
Humana Inc
|
$44.03B | +42.5% | +10.1% | 39.1 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CI | -9.0% | -4.4% | -3.7% | -1.8% | +0.7% |
| SPY | +4.1% | +3.2% | +11.4% | +3.3% | +13.1% |
| vs SPY | -13.1% | -7.6% | -15.1% | -5.0% | -12.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.